200 related articles for article (PubMed ID: 38040871)
1. Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer.
Geng H; Qian R; Zhong Y; Tang X; Zhang X; Zhang L; Yang C; Li T; Dong Z; Wang C; Zhang Z; Zhu C
Cancer Gene Ther; 2024 Feb; 31(2):334-348. PubMed ID: 38040871
[TBL] [Abstract][Full Text] [Related]
2. Mapping the landscape of synthetic lethal interactions in liver cancer.
Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
[TBL] [Abstract][Full Text] [Related]
3. Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.
Yamada L; Saito M; Thar Min AK; Saito K; Ashizawa M; Kase K; Nakajima S; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Kono K
Gastric Cancer; 2021 Jan; 24(1):60-71. PubMed ID: 32506298
[TBL] [Abstract][Full Text] [Related]
4. DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.
Das S; Deng X; Camphausen K; Shankavaram U
Bioinformatics; 2019 Feb; 35(4):701-702. PubMed ID: 30059974
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency.
Kwon JW; Oh JS; Seok SH; An HW; Lee YJ; Lee NY; Ha T; Kim HA; Yoon GM; Kim SE; Oh PR; Lee SH; Voon DC; Kim DY; Park JW
Mol Cancer; 2023 Sep; 22(1):156. PubMed ID: 37730636
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines.
De Kegel B; Quinn N; Thompson NA; Adams DJ; Ryan CJ
Cell Syst; 2021 Dec; 12(12):1144-1159.e6. PubMed ID: 34529928
[TBL] [Abstract][Full Text] [Related]
7. Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.
Wappett M; Dulak A; Yang ZR; Al-Watban A; Bradford JR; Dry JR
BMC Genomics; 2016 Jan; 17():65. PubMed ID: 26781748
[TBL] [Abstract][Full Text] [Related]
8. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
9. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
10. The tumor therapy landscape of synthetic lethality.
Zhang B; Tang C; Yao Y; Chen X; Zhou C; Wei Z; Xing F; Chen L; Cai X; Zhang Z; Sun S; Liu Q
Nat Commun; 2021 Feb; 12(1):1275. PubMed ID: 33627666
[TBL] [Abstract][Full Text] [Related]
11. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
[TBL] [Abstract][Full Text] [Related]
12. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
13. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential synthetic lethal genes to p53 using a computational biology approach.
Wang X; Simon R
BMC Med Genomics; 2013 Sep; 6():30. PubMed ID: 24025726
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
16. Overcoming selection bias in synthetic lethality prediction.
Seale C; Tepeli Y; Gonçalves JP
Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
[TBL] [Abstract][Full Text] [Related]
17. Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis.
Wang J; Shao X; Liu Y; Shi R; Yang B; Xiao J; Liu Y; Qu X; Li Z
Expert Rev Mol Diagn; 2021 Sep; 21(9):963-972. PubMed ID: 34196586
[No Abstract] [Full Text] [Related]
18. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
Weng S; Ruan H
FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
[TBL] [Abstract][Full Text] [Related]
19. Computational methods, databases and tools for synthetic lethality prediction.
Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
[TBL] [Abstract][Full Text] [Related]
20. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
